FTC Says Lax FDA Rules On Homeopathic Drugs Pose Conflict
The U.S. Food and Drug Admission's lack of rules requiring homeopathic drugmakers to support their product claims with scientific data stands in conflict with the Federal Trade Commission's requirements that product...To view the full article, register now.
Already a subscriber? Click here to view full article